Section 3: Prohibited activities, checks and investigations

The Committee referred to in article L. 232-2 comprises at least three doctors, chosen by the Chairman of the Agency from the list drawn up by the College of the Agency pursuant to article R. 232-10. The Committee appoints one of its members to act as secretary, with a casting vote in the event of a tie. The Committee secretary draws up and signs the minutes of the meeting, which…

The Therapeutic Use Exemption specifies the substance, its dosage and route of administration, or the method to which it relates. Any change to any of these elements shall be requested from the President of the Agency, who shall determine whether a new application for authorisation is required. The authorisation shall specify the duration for which it is granted and shall automatically expire at the end of the period for which…

Reasons are given for refusal of authorisation, in compliance with the rules set out in article L. 1110-4 of the Public Health Code. The applicant and, where applicable, the person(s) exercising parental authority or the legal representative of the person concerned, are notified of the refusal in a sealed envelope, together with the reasoned unfavourable opinion of the committee of experts provided for in article L. 232-2.

All the medical examinations and documents required to examine the authorisation application are at the applicant’s expense. The applicant pays a flat-rate contribution to the costs of this investigation, according to a tariff set by the agency.

The Therapeutic Use Exemption does not replace the certificate attesting to the absence of contraindication to participation in sporting competitions issued pursuant to article L. 231-2-1. It does not replace a doctor’s prescription for the substance or method whose use it authorises.

Decisions granting Therapeutic Use Exemptions are forwarded by the French Anti-Doping Agency to the World Anti-Doping Agency as well as to the International Federation concerned and, where applicable, to the foreign National Anti-Doping Organisation concerned, within twenty-one days of their notification. The same applies to decisions rejecting an admissible application. In accordance with Article L. 232-2, the French Anti-Doping Agency will review its decision if requested to do so by…

When the French Anti-Doping Agency decides to reject or grant an application for recognition of a Therapeutic Use Exemption issued by an International Federation or a body referred to in 4° of article L. 230-2, it shall inform the issuing authority and the World Anti-Doping Agency within twenty-one days.